Fidelity’s healthcare ETF offers a 0.08% expense ratio and 0.63 percentage point yield advantage over Invesco’s equal-weight fund.
Fidelity MSCI Health Care Index ETF (FHLC) undercuts Invesco S&P 500 Equal Weight Health Care ETF (RSPH) with a 0.08% expense ratio and a 0.63 percentage point higher dividend yield. FHLC’s $1.02 per-share payout over the past year reflects its market-cap-weighted structure, favoring large-cap stocks like Eli Lilly and Johnson & Johnson.
RSPH, by contrast, equal-weights its 64 holdings, reducing concentration risk but increasing volatility. FHLC’s 365 holdings are dominated by top names, with Eli Lilly accounting for 13.77% of assets. Both funds track U.S. healthcare but differ in risk and cost profiles.
Performance metrics show FHLC’s 1-year return and beta align closely with the S&P 500, while RSPH’s equal-weight approach may appeal to investors seeking broader sector exposure.